Use of a continous assay of oxygen consumption to evaluate the pharmacology of 5-lipoxygenase inhibitors
- 1 December 1993
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 49 (6), 929-937
- https://doi.org/10.1016/0952-3278(93)90178-y
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- The discovery and development of zileuton: An orally active 5-lipoxygenase inhibitorInternational Journal of Immunopharmacology, 1992
- Sensitivity of immunoaffinity-purified porcine 5-lipoxygenase to inhibitors and activating lipid hydroperoxidesBiochemical Pharmacology, 1989
- Soybean lipoxygenase-catalyzed oxidations by linoleic acid hydroperoxide: Different reducing substrates and dehydrogenation of phenidone and BW 755CBiochemical and Biophysical Research Communications, 1988
- Kinetic Studies on Arachidonate 5-Lipoxygenase from Rat Basophilic Leukemia CellsBiological Chemistry Hoppe-Seyler, 1988
- Reductive inactivation of soybean lipoxygenase 1 by catechols: a possible mechanism for regulation of lipoxygenase activityBiochemistry, 1987
- Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis.Annals Of The Rheumatic Diseases, 1983
- CHEMOTACTIC LIPOXYGENASE PRODUCTS IN PSORIASISThe Lancet, 1983
- Leukotriene B4General Pharmacology: The Vascular System, 1981
- Calcium stimulation of a novel lipoxygenaseBiochemical and Biophysical Research Communications, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976